Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
9.40
+0.12 (1.29%)
At close: Sep 4, 2026, 4:00 PM EDT
9.37
-0.03 (-0.32%)
After-hours: Sep 4, 2026, 7:51 PM EDT
Capricor Therapeutics Employees
Capricor Therapeutics had 231 employees as of December 31, 2025. The number of employees increased by 71 or 44.38% compared to the previous year.
Employees
231
Change (1Y)
71
Growth (1Y)
44.38%
Revenue / Employee
n/a
Profits / Employee
-$560,245
Market Cap
546.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 231 | 71 | 44.38% | 231 | 0 |
| Dec 31, 2024 | 160 | 58 | 56.86% | 160 | 0 |
| Dec 31, 2023 | 102 | 28 | 37.84% | 101 | 1 |
| Dec 31, 2022 | 74 | 26 | 54.17% | 74 | 0 |
| Dec 31, 2021 | 48 | 22 | 84.62% | 48 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| ARS Pharmaceuticals | 200 |
| Cabaletta Bio | 158 |
| Kyverna Therapeutics | 149 |
| Artiva Biotherapeutics | 115 |
| Scribe Therapeutics | 89 |
| Prelude Therapeutics | 79 |
| Prothena Corporation | 67 |
CAPR News
- 22 hours ago - Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) to Act Ahead of the Lead Plaintiff Deadline on September 28, 2026 - Newsfile Corp
- 1 day ago - Kaplan Fox Notifies Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of the Lead Plaintiff Deadline on September 28, 2026 - GlobeNewsWire
- 2 days ago - Kaplan Fox Alerts Capricor Therapeutics, Inc. (CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026 - Newsfile Corp
- 3 days ago - Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - GlobeNewsWire
- 3 days ago - $CAPR News: Capricor Therapeutics Sued for Securities Fraud Over Alleged Misrepresentations about its Clinical Data – Contact BFA Law by September 28 if You Lost Money - GlobeNewsWire
- 3 days ago - Kaplan Fox Urges Capricor Therapeutics, Inc. (CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - Newsfile Corp
- 4 days ago - Capricor Therapeutics upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 4 days ago - Capricor Therapeutics upgraded to Overweight from Neutral at Piper Sandler - TheFly